PILOCARPINE AND OTHER CHOLINERGIC DRUGS IN THE MANAGEMENT OF SALIVARY-GLAND DYSFUNCTION

被引:59
作者
FERGUSON, MM
机构
[1] Department of Oral Medicine and Oral Surgery, University of Otago Otago
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS | 1993年 / 75卷 / 02期
关键词
D O I
10.1016/0030-4220(93)90092-I
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Sialagogues constitute an important component in the management of salivary gland dysfunction. Of the pharmacologic agents available, pilocarpine has been used extensively over the last century. Many clinical trials have documented the efficacy of this alkaloid, with doses that range from 1 to 15 mg normally taken four times a day. There is considerable individual variation in response although it is usually possible, in the presence of sufficient responsive exocrine tissue, to establish a therapeutic regimen that promotes increased salivation without significant side effects.
引用
收藏
页码:186 / 191
页数:6
相关论文
共 66 条
[61]  
VOGEL J. J., 1965, ARCH ORAL BIOL, V10, P523, DOI 10.1016/0003-9969(65)90118-4
[62]   A DOUBLE-BLIND CROSSOVER TRIAL OF A MUCIN-CONTAINING ARTIFICIAL SALIVA [J].
WATTS, KD .
BRITISH DENTAL JOURNAL, 1989, 166 (09) :319-320
[63]  
Weber A., 1876, CENTRALLBLATT MED WI, V44, P769
[64]  
Weiss S, 1934, J PHARMACOL EXP THER, V52, P113
[65]  
WOLFE BB, 1989, MUSCARINIC RECEPTORS
[66]  
Zelles T, 1990, Fogorv Sz, V83, P319